Table 1 Patterns and trends in 5-year relative survival (%) and the deprivation gap in survival (%), with 95% confidence intervals (CIs): selected cancers, adults (aged 15–99 years) diagnosed in Scotland, 1986–2000

From: Socioeconomic inequalities in cancer survival in Scotland 1986–2000

	Five-year relative survival (%)						Deprivation gap in 5-year survival (%) ^a
	Patients diagnosed during 1996–2000			Average change (%) every 5 years over the period 1986–2000 ^b			Patients diagnosed during 1996–2000		Average change (%) every 5 years over the period 1986–2000
Malignancy	No. of patients	Five-year survival (%)	95% CI	No. of patients	Change (%)	95% CI	Deprivation gap (%)	95% CI	Change (%)	95% CI
Oesophagus
Men	2109	10.1	8.7–11.6	6302	2.3^c	1.5–3.2	−0.4	−4.6 to 3.9	1.1^c	0.5–1.8
Women	1424	9.8	8.2–11.6	4666	0.7	−0.5 to 1.8	−4.6	−9.3 to 0.2	−2.4^c	−3.2 to −1.5
Stomach
Men	2583	15.5	13.9–17.1	9586	2.7^c	1.4–3.9	1.5	−2.8 to 5.8	0.8^c	0.1 to 1.4
Women	1768	16.1	14.2–18.1	6479	2.4^c	1.4–3.5	−2.7	−7.8 to 2.5	−2.6^c	−3.5 to −1.8
Colon
Men	4969	50.8	49.0–52.4	15 409	4.6^c	3.2–6.0	−5.7^c	−10.1 to −1.2	−4.4^c	−5.2 to −3.5
Women	5061	51.0	49.4–52.6	17 216	4.9^c	3.7–6.1	−6.1^c	−10.2 to −1.9	−2.4^c	−3.2 to −1.6
Rectum
Men	3190	53.0	50.9–55.1	9506	7.8^c	6.1–9.5	−5.3	−10.7 to 0.2	−0.7	−1.8 to 0.4
Women	2227	56.0	53.4–58.5	7291	8.1^c	5.6–10.6	−8.0^c	−14.5 to −1.5	−2.9^c	−4.1 to −1.7
Larynx
Men	1128	67.3	63.7–70.6	3571	2.9	−0.9 to 6.7	−10.8^c	−19.9 to −1.8	−3.2^c	−5.0 to −1.4
Lung
Men	12 055	7.1	6.6–7.6	43 414	0.3^c	0.1–0.6	−1.6^c	−3.1 to −0.1	−0.6^c	−0.9 to −0.3
Women	8796	8.1	7.5–8.7	26 707	0.8^c	0.0–1.7	−1.5	−3.3 to 0.4	−1.2^c	−1.5 to −0.9
Melanoma
Men	1266	85.2	82.5–87.6	3671	4.0^c	1.3–6.7	−5.9	−12.3 to 0.5	1.3	−0.1 to 2.8
Women	1766	94.6	92.8–95.9	5511	1.4^c	0.2–2.6	−4.0^c	−7.6 to −0.5	−1.9^c	−2.8 to −1.1
Breast
Women	16 092	81.6	80.8–82.3	49 910	6.8^c	5.9–7.7	−4.1^c	−6.0 to −2.2	−0.2	−0.6 to 0.2
Cervix
Women	1654	70.9	68.3–73.2	6265	3.7^c	1.8–5.5	−4.6	−10.8 to 1.6	0.2	−1.0 to 1.3
Uterus
Women	1930	81.2	78.8–83.3	5821	2.9^c	0.5–5.3	−5.2	−10.7 to 0.3	−4.7^c	−5.8 to −3.5
Ovary
Women	2869	41.1	39.1–43.1	9162	5.3^c	3.4–7.3	−0.4	−5.6 to 4.8	0.8	−0.2 to 1.7
Prostate
Men	9370	72.0	70.7–73.4	26 673	10.8^c	8.4–12.7	−6.9^c	−10.3 to −3.4	−2.9^c	−3.7 to −2.2
Bladder
Men	3081	62.6	60.2–64.8	12 139	−1.5	−5.1 to 2.2	−6.7^c	−12.6 to −0.8	−4.0^c	−5.1 to −3.0
Women	1451	51.8	48.6–54.9	5521	−2.5	−6.0 to 1.0	−7.3	−15.4 to 0.7	−3.9^c	−5.3 to −2.4
Kidney
Men	1532	44.1	41.2–47.0	4612	2.2	−0.3 to 4.6	−5.2	−12.8 to 2.4	−3.1^c	−4.6 to −1.5
Women	1066	45.9	42.4–49.3	3240	5.4^c	3.2–7.6	−4.8	−13.8 to 4.2	0.3	−1.4 to 2.1
Brain
Men	942	17.7	15.2–20.3	2945	1.8^c	−0.1 to 3.7	4.8	−1.8 to 11.4	4.0^c	2.7–5.3
Women	744	17.3	14.5–20.2	2283	0.9	−1.3 to 3.1	−2.4	−9.4 to 4.5	0.7	−0.6 to 2.1
NHL
Men	1846	56.1	53.4–58.7	5710	4.8^c	1.8–7.8	−5.8	−12.6 to 1.1	1.9^c	0.5 to 3.2
Women	1972	53.8	51.2–56.4	5961	4.9^c	3.0–6.9	−2.9	−9.6 to 3.8	−0.5	−1.8 to 0.9
Myeloma
Men	674	31.0	26.7–35.2	2268	5.9^c	3.3–8.4	3.6	−8.6 to 15.7	−0.5	−2.5 to 1.5
Women	704	33.6	29.4–37.8	2329	4.3	−0.2 to 8.8	6.6	−5.2 to 18.4	7.7^c	5.7–9.8
Leukaemia
Men	1473	50.9	47.7–54.0	4554	7.7^c	5.2–10.1	1.0	−7.1 to 9.0	2.8^c	1.2–4.4
Women	1253	47.1	43.8–50.3	2787	8.1^c	5.1–11.0	−1.8	−10.2 to 6.7	−3.0^c	−4.5 to −1.4

^aThe deprivation gap shown as negative if fitted survival was lower in the most deprived than the most affluent group. The trend in the deprivation gap is shown as negative if the value became smaller (e.g. 6–4% or −3 to −5%), and positive if the value became larger.
^bAdjusted for deprivation (see text).
^cStatistically significant at 5%.

Back to article page

Table 1 Patterns and trends in 5-year relative survival (%) and the deprivation gap in survival (%), with 95% confidence intervals (CIs): selected cancers, adults (aged 15–99 years) diagnosed in Scotland, 1986–2000

Search

Quick links